Prioritizing risk genes as novel stratification biomarkers for acute Monocytic leukemia by integrative analysis
H He, Z Wang, H Yu, G Zhang, Y Wen, Z Cai - Discover Oncology, 2022 - Springer
Acute myeloid leukemia (AML) is a blood cancer with high heterogeneity and stratified as
M0–M7 subtypes in the French-American-British (FAB) diagnosis system. Improved …
M0–M7 subtypes in the French-American-British (FAB) diagnosis system. Improved …
Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal …
F He, M Chen, Y Liu, J Sun, J Zheng - Discover Oncology, 2022 - Springer
Background In locally advanced rectal cancer (LARC), the optimal sequence of neoadjuvant
chemotherapy in relation to neoadjuvant chemoradiotherapy and before total mesorectal …
chemotherapy in relation to neoadjuvant chemoradiotherapy and before total mesorectal …
SRSF2 transcriptional function maintains genome integrity during cell division
RE Wagner, L Arnetzl, T Britto-Borges, A Heit-Mondrzyk… - bioRxiv, 2024 - biorxiv.org
Recurrent mutations in serine/arginine-rich splicing factor 2 (SRSF2), particularly the proline-
to-histidine substitution at position 95 (P95H), have been proposed to drive neoplastic …
to-histidine substitution at position 95 (P95H), have been proposed to drive neoplastic …